News
World Alzheimer’s Month: How MultiPark research contributes to understanding, diagnosing and treating Alzheimer’s disease
New biomarkers can make Alzheimer’s disease easier to detect and diagnoses more accurate, which may be crucial as disease-modifying treatments are available. And the diagnostic too...
STEM-PD announces first in-human clinical trial results for Parkinson’s disease cell therapy
A landmark study led from Lund, Sweden, has shown that transplanting stem-cell derived dopamine progenitor cells into the brain is feasible. Eight patients were transplanted in the...
Millions for brain research into dementia
The risk of neurodegenerative diseases increases markedly after a traumatic brain injury – particularly following repeated concussions. Professors Niklas Marklund and Tadeusz Wielo...
MultiPark grows – A new research group focusing on Neural Circuits of Emotion
This spring, MultiPark has the pleasure of welcoming a new research group leader. The Neural Circuits of Emotion team focuses on how neural circuits and neuroimmune interactions re...
Exceptional Success of MultiPark Researchers in a Highly Competitive International Call for Parkinson’s Research
A team of international researchers led by senior lecturer Åsa Mackenzie at Lund University has received a $9 million USD grant from the Aligning Science Across Parkinson’s (ASAP) ...